ESS vs SLS · P/E 31, rev $1.89B vs $1.62B cap
Essex Property Trust Inc (ESS) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$9.6M. SLS currently screens at market cap $1.62B.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. SLS currently screens at market cap $1.62B.
Not investment advice. Open the ESS and SLS stock pages for the full models.
Not investment advice.